UPR.L Stock - Uniphar plc
Unlock GoAI Insights for UPR.L
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.77B | $2.55B | $2.07B | $1.94B | $1.82B |
| Gross Profit | $427.60M | $389.98M | $306.74M | $274.50M | $217.25M |
| Gross Margin | 15.4% | 15.3% | 14.8% | 14.1% | 11.9% |
| Operating Income | $81.99M | $67.71M | $53.16M | $45.15M | $39.94M |
| Net Income | $64.20M | $44.81M | $45.59M | $48.08M | $27.83M |
| Net Margin | 2.3% | 1.8% | 2.2% | 2.5% | 1.5% |
| EPS | $0.24 | $0.16 | $0.17 | $0.18 | $0.11 |
Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
Visit WebsiteEarnings History & Surprises
UPR.LEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 23, 2026 | — | — | — | — |
Q3 2025 | Sep 2, 2025 | $0.08 | $0.06 | -29.2% | ✗ MISS |
Q1 2025 | Feb 25, 2025 | $0.11 | $0.15 | +39.8% | ✓ BEAT |
Q3 2024 | Sep 3, 2024 | $0.07 | $0.05 | -28.7% | ✗ MISS |
Q2 2024 | May 9, 2024 | $0.10 | $0.09 | -3.0% | ✗ MISS |
Q2 2023 | Jun 30, 2023 | $0.07 | $0.05 | -30.3% | ✗ MISS |
Q4 2022 | Dec 31, 2022 | $0.09 | $0.10 | +7.3% | ✓ BEAT |
Q2 2022 | Jun 30, 2022 | $0.08 | $0.03 | -60.7% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | — | $0.10 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.05 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.05 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.04 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $0.07 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.08 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.01 | — | — |
Q1 2018 | Jan 31, 2018 | — | $0.01 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.00 | — | — |
Q1 2017 | Jan 31, 2017 | — | $-0.00 | — | — |
Q2 2016 | Jun 30, 2016 | — | $0.01 | — | — |
Latest News
Frequently Asked Questions about UPR.L
What is UPR.L's current stock price?
What is the analyst price target for UPR.L?
What sector is Uniphar plc in?
What is UPR.L's market cap?
Does UPR.L pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to UPR.L for comparison